Maintenance of CD8+ T-Cell Memory Following Infection with Recombinant Sindbis and Vaccinia Viruses  by Villacres, Maria C. et al.
r
a
M
i
s
a
m
Virology 270, 54–64 (2000)
doi:10.1006/viro.2000.0255, available online at http://www.idealibrary.com onMaintenance of CD81 T-Cell Memory Following Infection
with Recombinant Sindbis and Vaccinia Viruses
Maria C. Villacres,*,1 Jun Zuo,† and Cornelia C. Bergmann*,†,2
*Department of Neurology and †Department of Molecular Microbiology and Immunology, University of Southern California Keck
School of Medicine, Los Angeles, California 90033
Received October 26, 1999; returned to author for revision January 10, 2000; accepted February 17, 2000
CD81 T-cell memory is critical for protection against pathogens poorly controlled by humoral immunity. To characterize two
distinct vaccine vectors, the acute and memory CD81 T-cell responses to an HIV-1 epitope (p18) expressed by recombinant
vaccinia (vp18) and Sindbis (SINp18) viruses were compared. Whereas 9 to 13% of CD81 splenocytes were p18 specific
during the acute response to vp18, 4% were induced by SINp18 as revealed by class I tetramer staining. Increased T-cell
activation by vp18 was confirmed by higher numbers of both p18-specific IFN-g-secreting splenocytes and activated CD81
and CD41 T cells. Although higher frequencies of p18-specific CD81 T cells during primary responses correlated with higher
frequencies during memory, the overall decline was only two- to threefold during the transition to memory, demonstrating
equally efficient maintenance of memory in SINp18- as in vp18-immune mice. Despite modest in vivo activation, SINp18-
induced CD41 T cells secreted substantial amounts of IFN-g and IL-2, potentially contributing to sustained CD81 memory.
Collectively the data indicate that Sindbis virus recombinants provide effective vaccines for inducing protective memory
CD81 T cells in the absence of the extensive inflammation and replication associated with vaccinia virus. © 2000 Academic Press
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The acute immune response to many viral infections is
characterized by a rapid and prominent expansion of
CD81 T cells, which are critical for the control of viral
eplication and spread (Ahmed and Gray, 1996). The
bility to detect antigen-specific T cells using tetrameric
HC reagents revealed that expansion resides predom-
nantly in the virus-specific CD81 population and is con-
iderably larger than previously estimated by functional
ssays (Altman et al., 1996; Callan et al., 1998; Flynn et
al., 1998; Murali-Krishna et al., 1998). As effector function
develops concomitantly with proliferation, the size of the
antigen-specific CD81 population is indicative of both
the potency of the response and the ability to suppress
viral replication (Flynn et al., 1998; Murali-Krishna et al.,
1998). Coincident with viral clearance, the vast majority
of activated virus-specific CD81 T cells undergo apopto-
sis, with a variable, but small proportion persisting as
memory cells (Ahmed and Gray, 1996; Murali-Krishna et
al., 1998). Following viral clearance, the relative fre-
quency of distinct peptide-specific memory populations
is generally proportional to the initial expansion, inde-
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54pendent of epitope specificity (Busch et al., 1998; Murali-
Krishna et al., 1998). As memory cells are capable of
more rapid activation than naive CTL precursors they
play an important role in providing protection against
reinfection (Ahmed and Gray, 1996).
The induction of naive CD81 T cells by vaccination is
therefore critical for establishing an effective memory
pool specific for high-risk pathogens. CD81 T-cell-medi-
ated cytolytic function and secretion of antiviral factors
are especially vital components in controlling and pro-
viding protection against HIV-1 infection (Shearer, 1998;
Yang and Walker, 1997) and SIV infection in macaques
(Jin et al., 1999; Johnson et al., 1997; Schmitz et al., 1999).
Both cytolytic activity and secretion of soluble factors
should thus be triggered as protective components of
CD81 T cells. However, the extent to which recombinant
accines, selected for minimal pathogenicity, activate
unctionally homogeneous or heterogeneous CD81 T
cells has not been previously analyzed. Although infec-
tions associated with prominent viral replication (e.g.,
acute influenza virus or lymphocytic choriomeningitis
virus [LCMV] infections) appear to activate a functionally
homogeneous population (Flynn et al., 1998; Murali-
rishna et al., 1998), other studies suggest that CD81 T
ells may be functionally diverse with respect to cytokine
roduction and cytolysis (Carter and Dutton, 1995; Croft
t al., 1994; Erard et al., 1993; Li et al., 1997). Furthermore,
here is considerable variation in the requirement for
1D4 T cells in the expansion, function, and survival of
D81 T cells following different types of viral infections
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55T-CELL RESPONSES TO RECOMBINANT vp18 AND SINp18 VIRUSES(Jennings et al., 1991; Kalams and Walker, 1998; Koszi-
nowski et al., 1991; Matloubian et al., 1994; Stohlman et
l., 1998; Zajac et al., 1998). However, the role of CD41 T
cells in promoting CD81 T-cell responses to recombinant
accines has also not been explored extensively.
The multitude of viral and bacterial recombinant vec-
ors provides a source to identify selective effects of
ifferent vectors on immune responses to a single anti-
enic determinant and to enhance specific T-cell re-
ponses (Murata et al., 1996; Rodrigues et al., 1994;
lifka et al., 1996). Current live, attenuated vaccines aim-
ng to elicit CD81 T-cell components against HIV include
redominantly poxvirus vectors (McMichael, 1998). Pro-
uctively replicating vaccinia viruses (VV) elicit promi-
ent cell-mediated type 1 responses including CD81 T
cells and provide long-lasting cell-mediated immunity
(Demkowicz et al., 1996). However, attenuated poxvi-
ruses induce modest cell-mediated immunity, prompting
efforts for enhancement by booster immunizations (Fer-
rari et al., 1997; Fleury et al., 1996). Members of the alpha
viruses have also received considerable attention as
vaccine and gene therapy vectors (Davis et al., 1996;
Driver et al., 1998; Dubensky et al., 1996; Frolov et al.,
996). The vaccine potential of attenuated alphavirus
ectors has been demonstrated by providing protection
gainst murine malaria, influenza virus, and lethal en-
ephalitis caused by Japanese encephalitis virus (Davis
t al., 1996; Pugachev et al., 1995; Tsuji et al., 1998) and
y their ability to elicit mucosal immunity (Davis et al.,
996). Although these vectors provide versatile systems
or efficient expression of foreign antigens using either
ttenuated recombinants or replication-incompetent rep-
icon particles (Driver et al., 1998; Frolov et al., 1996), the
mmune responses elicited are incompletely understood.
learance of alphaviruses is primarily mediated by anti-
odies (Griffin et al., 1997) and involves a type 2 cytokine
esponse for neurotropic Sindbis (SIN) virus strains
Wesselingh et al., 1994). Although CD81 T cells are
primed by alphaviruses, they do not appear to play a
prominent role in providing protection in vivo (Linn et al.,
998).
To characterize the relationship between acute and
emory T-cell responses elicited by recombinant vi-
uses, this report compares CD81 T-cell responses with
those of a class I-restricted HIV-1IIIB gp120 epitope (p18)
expressed as a 10-amino acid peptide by either recom-
binant vaccinia virus (rVV) or recombinant Sindbis virus
(rSIN), designated vp18 and SINp18, respectively (Berg-
mann et al., 1993, 1994). Both viruses induced predomi-
nantly type 1 cytokine responses in BALB/c mice, as
revealed by class I tetramer staining and IFN-g ELISPOT
analysis for p18-specific CD81 T cells, expression of
ctivation markers on both CD41 and CD81 T cells, and
ytokine secretion by CD41 T cells. Although vp18 elic-
1ited more-potent expansion of p18-specific CD8 T cells
ompared with SINp18, differences were less marked inhe residual memory populations. Notably, frequencies of
18-specific IFN-g-secreting CD81 T cells in either mem-
ry pool were reduced by only two- to threefold relative
o the acute response, indicating highly efficient reten-
ion of memory CD81 T cells, not only in vp18- but also in
SINp18-immune mice. Cytokine responses differed pri-
marily by higher IL-2 secretion, but lower IFN-g secretion
by CD41 T cells from SINp18 compared with vp18-in-
ected mice. The data demonstrate that, despite their
odest ability to mount primary T-cell responses, atten-
ated rSIN-based vectors provide effective vaccines for
nducing protective memory CD81 T-cell populations in
the relative absence of primary inflammatory immune
responses.
RESULTS
Epitope-specific CD81 T-cell expansion
BALB/c (H-2d) mice were injected with SINp18 or vp18
expressing the gp160-derived, Dd-restricted p18 epitope
o assess the magnitude of p18-specific CD81 T-cell
xpansion during the acute response. Tetrameric class I
olecules were used to phenotypically detect p18-spe-
ific TCR expression on splenic CD81 T cells; Fig. 1A
illustrates that vp18 elicited a distinct population of Dd/
181 T cells in the CD8 compartment, approximating 9%
at Day 7 postinjection (p.i.). By contrast, expansion of
p18-specific CD81 T cells elicited by the identical dose of
INp18 was less than that observed following vp18 im-
unization, approximating 4% (Fig. 1A). Differences be-
ween the groups were more pronounced when spleen
ellularity was taken into account (Fig. 1B). Spleens from
p18-injected mice showed a 2.5-fold increase in cell
umber with only a slightly higher percentage of CD81 T
cells (251 6 28 3 106 cells/spleen with 12.5 6 0.6% CD81
T cells) at Day 7 compared with naive controls (100 3 106
cells/spleen with 10% CD81 T cells). By contrast, spleens
from SINp18-injected mice increased only 1.4-fold in size
(140.5 6 5.7 3 106 cells/spleen with 10.0 6 0.5% CD81 T
cells). The increased number of CD81 T cells in spleens
from vp18- compared with SINp18-injected mice, in ad-
dition to the twofold higher percentage of Dd/p181 cells
in the CD81 population, resulted in a four- to fivefold
increase in p18-specific CD81 splenocytes following
p18 injection.
x vivo effector function of CD81 T cells
The primary response to either SINp18 or vp18 re-
ulted in barely detectable p18-specific ex vivo CTL ac-
ivity at effector-to-target ratios of 100:1 (,15% specific
ysis; data not shown). By contrast, functional p18-spe-
ific CD81 T cells secreting IFN-g were readily detected
ex vivo by ELISPOT (Fig. 2). In splenocytes from vp18-
infected mice, p18-specific T cells were detectable as
early as Day 2 p.i., and their frequency increased 10-fold
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56 VILLACRES, ZUO, AND BERGMANNby Day 6 p.i. By contrast, p18-specific splenocytes from
SINp18-injected mice showed limited expansion by Day
4 p.i., with no further increase by Day 6 p.i. Thus, at Day
6 p.i. the frequencies of IFN-g-secreting cells were five-
old higher in splenocytes of vp18- compared with
INp18-injected mice. The reduced frequency of spleno-
ytes responding to SINp18 compared with vp18 could
ot be overcome by two- or 10-fold higher immunization
oses (1 3 108 or 1 3 109 plaque-forming units [PFU];
data not shown). Splenocytes cultured with an irrelevant
peptide or without peptide did not secrete IFN-g (,10
ells/106 splenocytes; data not shown). Correcting for the
ncreased spleen size following vp18 infection, spleno-
FIG. 1. Expansion of p18-specific CD81 T cells during the primary res
ith SINp18 or vp18 were double-stained 7 days later for CD8- and p18-
plots of FACS analyses indicating the respective percentage of positive
with naive splenocytes (right panel). The percentage of Dd/p181 cells in
number of cells per spleen in SINp18- (open bars) or vp18-inoculated (b
number of Dd/p181 CD81 T cells per spleen. *, statistically signifi
epresentative of at least five independent experiments with similar re
ge-matched naive BALB/c mice.
FIG. 2. Frequencies of epitope-specific IFN-g-secreting cells.
Splenocytes from mice (n 5 3) injected with SINp18 or vp18 were
ecovered 2, 4, or 6 days later and analyzed for p18-peptide-induced
FN-g secretion by ELISPOT. Frequencies are expressed as the number
f IFN-g-secreting cells per 106 splenocytes. Error bars represent SDa
p
from three to six wells. The data are representative of four independent
experiments with similar results.ytes from vp18-infected mice contained at least a 12-
old higher absolute number of p18-responsive T cells
uring the primary response.
iral vectors stimulate different cytokine profiles
n CD41 T cells
Wild-type SIN infection elicits a potent antibody re-
ponse and type 2 cytokines (Griffin et al., 1997; Levine et
l., 1991; Wesselingh et al., 1994). Therefore, the possi-
ility was examined that CD81 T-cell expansion in
SINp18-injected mice may be compromised by type 2
cytokine responses. Secretion of type 1 (IL-2 and IFN-g)
nd type 2 (IL-4, IL-5, and IL-10) cytokines by CD41 T
cells recovered 7 days p.i. was measured following in
vitro stimulation with UV-inactivated SINp18 or vp18 (Fig.
3A). SINp18-induced CD41 T cells secreted substantial
amounts of IL-2 and IFN-g, but only low levels of IL-10.
Furthermore, neither IL-4 nor IL-5 was detectable in
either virus-stimulated culture (data not shown). Com-
pared with SINp18-primed splenocytes, splenocytes ac-
tivated by vp18 secreted less IL-2, but fourfold more
IFN-g. However, vp18-primed splenocytes also secreted
ore IL-10, although secretion of IL-4 and IL-5 was
ndetectable, similar to the response elicited by SINp18.
his pattern of cytokine secretion was confirmed by
timulation of activated CD41 T cells with a low concen-
ration of anti-CD3 mAb for 18 or 40 h (Fig. 3B). Similar to
Splenocytes from individual mice (n 5 4) injected intraperitoneally (ip)
T-cell receptor expression using Dd/p18 tetramers. (A) Representative
vp18- (left panel) or SINp18-inoculated (center panel) mice compared
spective CD8 population is shown in parentheses. (B) Left panel, total
rs) mice; center panel, number of CD81 T cells per spleen; right panel,
ifferences between experimental groups (P , 0.01). The data are
rror bars represent SD. Horizontal lines represent average values inponse.
specific
cells in
the re
lack ba
cant dntigen-specific stimulation, the most abundant cytokine
roduced by either vp18- or SINp18-primed CD41 T cells
l
t
w
d
c
s
w
c
I
c
l
h
s
n
s
e
t
D
c
v
d
p
p
m
p
t
c
v
a
s
s
r
57T-CELL RESPONSES TO RECOMBINANT vp18 AND SINp18 VIRUSESwas IFN-g, with cells from vp18-injected mice secreting
ess IL-2, but more IFN-g compared with SINp18. Al-
hough cytokine levels were higher following stimulation
ith anti-CD3 compared with inactivated virus, no evi-
ence was obtained for preferential secretion of type 2
ytokines by SINp18-induced splenocytes. In both
plenic populations secretion of IL-10 was prominent,
hile IL-4 and IL-5 were detectable only at minimal
oncentrations (,60 pg/ml for IL-4 and ,160 pg/ml for
L-5; data not shown). These data suggested that type 2
ytokine responses do not contribute to lower CD81
T-cell priming by SINp18.
T-cell activation phenotype and viral replication
Prominent expansion of p18-specific CD81 T cells fol-
owing vp18 injection may be attributed to overall en-
anced T-cell activation by VV compared with SIN. A
trong CD81 T-cell response is elicited by VV in H-2d
mice (Takahashi et al., 1988); however, the epitopes have
ot been delineated. Furthermore, although SIN re-
ponses were initially reported to be limited to the H-2k
haplotype (Mu¨llbacher and Blanden, 1978), recent stud-
ies demonstrate CD81 T-cell priming of a response in
H-2d mice (Linn et al., 1998). Class I-restricted CTL re-
sponses elicited by epitopes within both SIN and VV
viruses thus contribute to total CD81 T-cell expansion. To
determine whether differences in expansion of p18-spe-
cific T cells reflected different overall levels of lympho-
cyte activation following injection of either virus, CD81
1
FIG. 3. Differential secretion of cytokines by CD41 T cells. Spleno-
cytes from SINp18- (open bars) or vp18-injected (solid bars) mice (n 5
3) were recovered 7 days postinjection (p.i.) and depleted of CD81 T
ells. (A) CD8-depleted splenocytes were cultured with UV-inactivated
iruses (1) or medium alone (2) and supernatants analyzed for IL-2
fter 48 h, or IL-10 and IFN-g after 96 h, respectively. (B) CD8-depleted
plenocytes were stimulated with anti-CD3 mAb for 18 or 40 h and
upernatants analyzed by ELISA. Error bars represent SD. The data are
epresentative of three independent experiments with similar results.and CD4 splenocyte populations were monitored for
xpression of CD11a, CD44, and CD62L (Fig. 4). Charac-eristic profiles of activation markers on splenocytes at
ay 7 p.i. showed increased percentages of CD81 T
ells with the CD11ahi, CD44hi, and CD62Llo phenotype in
p18- compared with SINp18-injected mice (Fig. 4A), in-
icating enhanced activation. Figure 3B shows relative
ercentages of activated populations at various time
oints p.i. Whereas the percentage of activated CD81 T
cells increased steadily up to Day 7 p.i. with vp18, the
activated CD81 population in splenocytes from SINp18-
injected mice was overall low in comparison throughout
the same 7-day period (Fig. 4B, upper panel). Further-
more, the percentages of activated cells were lower
within the CD41 compared with the CD81 T-cell compart-
ent during the response to both viruses (Fig. 3B, lower
anel). Nevertheless, vp18 elicited more pronounced ac-
ivation of CD41 T cells compared with SINp18.
The reduced numbers of activated T cells following
SINp18 immunization indicated a weak T-cell response
that may be the result of reduced numbers of antigenic
epitopes, minimal viral replication, or migration of T cells
to distal sites. While ovaries are a primary target organ
for rVV replication (Karupiah et al., 1990), to our knowl-
edge, a preferential site of rSIN replication following
peripheral administration has not been reported. Mea-
surement of vp18 titers in the ovaries as the predominant
site of infection typically yielded approximately 6 log10
per ovary pair per mouse at Days 5 and 7 p.i., demon-
strating productive replication (Table 1). By contrast, de-
termination of SIN titers in serum showed a rapid decline
by Day 2 with titers dropping below detection by Day
3 p.i. (Table 1). These data are indicative of a minimal
productive infection following ip administration of
SINp18.
Retention of memory CD81 T cells
Initial expansion of CD81 T cells during acute infection
generally correlates with the size of the resulting mem-
ory CD8 pool after pathogen clearance (Busch et al.,
1998; Murali-Krishna et al., 1998; Slifka et al., 1996).
However, vp18 infection is associated with high levels of
replicating virus and a more vigorous T-cell response
compared with SINp18, suggesting that a higher propor-
tion of antigen-specific T cells may undergo apoptosis as
a result of increased antigen-driven differentiation (Com-
badiere et al., 1998; Lenardo et al., 1999). To characterize
the memory response following SINp18 or vp18 priming,
relative frequencies of p18-specific CD81 T cells during
the acute response (7 days p.i.) were compared pheno-
typically and functionally to those retained during mem-
ory (4–6 weeks p.i.). Class I tetramer staining revealed
that in vp18-primed mice 5% of CD81 T cells were p18
specific during memory, relative to 13% during the acute
response (Fig. 5A). Thus the frequencies of p18-specific
cells had dropped only 2.5-fold. The low percentages of
tetramer-positive cells initially primed by SINp18 injec-
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58 VILLACRES, ZUO, AND BERGMANNtion (see Fig. 1) preempted an accurate phenotypic as-
sessment of memory T cells. Acute and memory re-
sponses were therefore compared by determining the
frequencies of p18-specific IFN-g-secreting cells. The
requencies of p18-specific cells declined approximately
hreefold compared with the acute response in vp18-
mmune mice, confirming high retention of memory T
ells at the functional level (Fig. 5B).
Similarly, only a 50% decline in frequencies of p18-
pecific IFN-g-secreting T cells was observed when
omparing SINp18-induced splenocytes during the acute
r memory phase (Fig. 5B). These declines represented
surprisingly minimal loss compared with those which
ccur following infections with LCMV, influenza, and Sen-
ai virus (Murali-Krishna et al., 1998; Flynn et al., 1998;
FIG. 4. Expression of activation markers on CD41 or CD81 splenocyt
at 7 days p.i. (n 5 3) and stained for expression of CD8 and CD11a, CD4
3, 5, or 7 days p.i. with SINp18 (open circles) or vp18 (closed squares)
(right column). The data are representative of three independent expesherwood et al., 1999). Furthermore, direct comparison
f vp18- and SINp18-induced memory suggested that
p
trequencies of p18-specific IFN-g-secreting CD81 T cells
ere at most threefold higher in vp18-immune mice (Fig.
B). The increased capacity of CD81 T cells from vp18-
ersus SIN p18-immune mice to secrete IFN-g was con-
firmed by ELISA of culture supernatants from CD81 T-
cell-enriched populations stimulated with p18 peptide
(Fig. 5C). IFN-g secretion peaked at Day 3 in both cul-
ures. However, IFN-g secretion by vp18-immune mem-
ory cells was higher compared with SINp18, correlating
with the higher frequency of IFN-g-secreting cells (Fig.
C). These data suggested that on a per cell basis,
emory CD81 T cells from vp18- and SINp18-immunized
mice have similar capacity to secrete IFN-g. To assess
the cytolytic capacity of memory CD81 T cells, spleno-
ytes from immune mice were restimulated with p18
epresentative plots of FACS analyses of CD81 splenocytes recovered
62L. (B) CD81 (upper row) or CD41 (lower row) splenocytes recovered
tained for either CD11a (left column), CD44 (center column), or CD62L
with similar results.es. (A) R
4, or CDeptide for 48 h and tested for lysis of peptide-coated
arget cells (Fig. 5D). A short stimulation period was
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59T-CELL RESPONSES TO RECOMBINANT vp18 AND SINp18 VIRUSESchosen to minimize proliferation (Oehen and Brduscha-
Riem, 1998; Usherwood et al., 1999). Memory T cells from
vp18-immune mice exerted potent cytolytic activity, con-
firming rapid stimulation of effector function. SINp18-
immune T cells also exhibited lytic activity, albeit at lower
levels than splenocytes from vp18-immune mice. Early
activation of lytic activity, prior to extensive cell division
(Usherwood et al., 1999), suggested that the reduced
lytic capacity by SINp18-immune T cells reflects reduced
frequencies of p18 memory T cells rather than inherently
lower activation state.
The pattern of IL-2 and IFN-g secretion elicited by
each virus in CD41 T cells was also maintained during
he memory phase as shown by ELISA of culture super-
atants from CD8-depleted splenocytes recovered 4
eeks p.i. and stimulated with UV-inactivated virus (Fig.
). Similar to the acute response, splenocytes from
INp18-immune mice secreted more IL-2 than those
rom vp18-immune mice. Furthermore, vp18-induced
emory CD41 T cells retained their stronger potential to
secrete IFN-g. IL-4 secretion remained undetectable in
ither memory population and in contrast to the acute
esponse, IL-10 secretion was not preferentially induced
n vp18-immune splenocytes (data not shown).
To confirm memory function of p18-specific CD81 T
cells elicited by SINp18 in vivo, SINp18-immunized mice
were challenged 4 weeks p.i. by infection with vp18, and
viral titers in ovaries were determined 6 days later. Ova-
ries from immunized groups were normal in size after
challenge compared with nonimmunized controls, indi-
cating control of vp18 replication. Replication was re-
duced by 3 log10 in SINp18-immune mice compared with
aive controls (Fig. 7). Complete protection in 5 of 8
hallenged mice suggested that SINp18 at a dose of 5 3
07 PFU provided partial protection. A 10-fold higher
ose of SINp18 (5 3 108 PFU) provided complete protec-
tion against vp18 challenge, as shown by complete clear-
ance of the challenge virus in all immunized mice by 6
TABLE 1
Viral Titers Following Inoculation with vp18 and SINp18a
vp18 SINp18
PFU/ovary pair (log10) PFU/ml serum (log10)
Day 5 6.67 6 0.12 Day 1 3.14 6 0.27
Day 7 6.19 6 0.03 Day 2 0.1 6 0.01
Day 3 —
Day 4 —
a Mice were injected with 5 3 107 PFU vp18 or SINp18 ip and
monitored for vp18 titers in ovaries at Days 5 and 7 and for infectious
SINp18 in serum at Days 1 to 4 postinjection. Titers were determined by
plaque assay and are the means 6 SE of three individual mice per time
point.days p.i. (Fig. 7). These data demonstrate that sufficient
p18-specific memory T cells are retained in SINp18-
N
fimmune mice to provide substantial immunity to chal-
lenge with a heterologous virus expressing a single
common epitope.
DISCUSSION
Induction of a robust T-cell response is frequently
associated with protection against reinfection. However,
the relationship between acute and memory responses
to experimental recombinant vaccines designed to in-
duce T-cell responses is poorly understood. This report
demonstrates efficient maintenance of memory CD81 T
cells specific for an HIV epitope following inoculation of
two heterologous vaccine vectors: a rSIN with apparently
limited capacity of in vivo replication, but high capacity
for expression of recombinant antigen, and a produc-
FIG. 5. Retention of p18-specific CD81 T cells during memory. (A)
Representative plots of FACS analyses showing the percentage of
Dd/p181 cells within the splenic CD81 population at 7 days (acute) or
weeks (memory) p.i. with vp18 (3 mice per group). The percentage of
d/p181 cells in the respective CD81 population is shown in parenthe-
ses. (B) The frequencies of p18-specific CD81 T cells were determined
y ELISPOT in splenocytes (3 mice per group) recovered 6 weeks after
mmunization (open circles) and during the acute response (closed
ircles). Frequencies are expressed as the number of IFN-g-secreting
cells per 106 splenocytes and shown for two independent experiments.
(C) CD4-depleted T cells from immune mice 4 weeks p.i. were stimu-
lated with p18 peptide and IFN-g secretion measured by ELISA. For
reference, the frequencies of p18-specific IFN-g-secreting memory T
ells per 106 immune splenocytes prior to CD4 depletion were 258 6 26
in SINp18 and 523 6 62 in vp18-immune splenocytes, respectively. The
ata are representative of two independent experiments with similar
esults. (D) Splenocytes from immune mice 4 weeks p.i. were stimu-
ated with p18 peptide in vitro for 48 h. Cytolytic activity was measured
sing J774.1 cells coated with p18 peptide at the indicated E:T ratios.
onspecific lysis of untreated targets was less than 5% and subtracted
rom specific lysis.
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60 VILLACRES, ZUO, AND BERGMANNtively replicating rVV. Relative to the acute response to
vp18 or SINp18, the frequencies of p18-specific CD81 T
ells during memory were reduced only two- to threefold.
hese data confirm the well-documented long-term
D81 T-cell memory associated with VV infection
Demkowicz et al., 1996) at a single epitope level and
emonstrate equally sufficient maintenance of T-cell
emory following rSIN priming. This efficient retention of
emory cells is comparable to a 20–30% survival rate of
ntigen-specific CD81 T cells observed following Listeria
infection (Busch et al., 1998), but is significantly higher
han the 5% survival rate found following LCMV infection
Murali-Krishna et al., 1998).
In many infections the size of the memory pool corre-
lates with the initial burst size of each antigen-specific
T-cell population primed during the acute response.
However, both the relative survival and absolute frequen-
cies of memory T cells can vary significantly between
different viral infections (Flynn et al., 1998; Murali-Krishna
et al., 1998; Usherwood et al., 1999), even for those
pathogens targeting the same organ (Flynn et al., 1998;
Usherwood et al., 1999). Consistent with this notion,
higher frequencies of p18-specific memory CD81 T cells
n vp18-immune mice reflected higher frequencies during
he acute response. Thus, a two- to threefold higher
18-specific memory T-cell population was detected in
p18- compared with SINp18-immune mice. However, in
ontrast to similar spleen sizes during memory, markedly
nhanced splenic cellularity in vp18-primed mice during
he acute response accounted for significantly higher
bsolute numbers of p18-specific CD81 T cells; this in-
icated a greater net loss of p18-specific cells during the
ransition to memory. Splenomegaly correlated with over-
ll increased lymphocyte activation in response to vp18
ompared with SINp18. The relatively high retention of
emory CD81 T cells in SINp18-immune mice may thus
e attributed to more limited apoptosis, which is gener-
lly associated with high-dose antigen or cytokine depri-
ation concurrent with viral clearance (Lenardo et al.,
FIG. 6. The cytokine secretion profile in CD41 T cells during memory.
Splenocytes from SINp18- or vp18-immune mice (n 5 3) recovered 4
weeks p.i. were depleted of CD81 T cells and cultured for 6 days with
UV-inactivated virus. Supernatants recovered every 24 h were analyzed
by ELISA. Error bars represent SD. The data are representative of two
experiments with similar results.999). Similar to vp18, SINp18 activated predominantly
D81 rather than CD41 T cells. Nevertheless, SINp18-primed splenocytes displayed an efficient capacity to
secrete IL-2 and IFN-g, not predicted by the low percent-
ages of activated CD41 T cells. Indeed, the enhanced
L-2 secretion by SINp18 compared with vp18-induced
plenocytes may contribute to CD81 T-cell survival (Hom
t al., 1991; Matloubian et al., 1994; Zajac et al., 1998).
The potency of an antiviral T-cell response is influ-
enced by the relative abundance of immunogenic
epitopes, viral tropism, and the extent of replication. The
significantly increased proportion of total activated T
cells primed by vp18 compared with SINp18 likely corre-
lates with both the greater complexity of the immune
response to additional epitopes in VV (Takahashi et al.,
1988) and more extensive viral replication. The VV ge-
nome encodes for more than 100 polypeptides (Buller
and Palumbo, 1991) and VV-specific CD81 T-cell re-
sponses in BALB/c mice may enhance the response to
the engineered p18 epitope. Furthermore, VV derivatives
replicate to high titers predominantly in ovaries (Karu-
piah et al., 1990; Binder and Ku¨ndig, 1991). By contrast,
SIN virions encode for less than 10 proteins (Strauss and
Strauss, 1994). Although early studies implicated a vari-
ety of mouse strains as non-CD81 T-cell responders to
ild-type SIN (Mu¨llbacher and Blanden, 1978), a con-
erved epitope in the capsid protein was recently iden-
ified in H-2d mice (Linn et al., 1998). The laboratory-
dapted parental hybrid SIN strain used in the present
tudy is neurotropic and lethal following intracerebral
njection of weanling mice (Lustig et al., 1988). However,
p inoculation of engineered derivatives to 3-week-old
ice resulted neither in death nor any apparent illness
Pugachev et al., 1995). Effective containment and lack of
ymptoms following several routes of rSIN inoculation
as subsequently confirmed in adult mice (Tsuji et al.,
998). The inability to detect infectious SINp18 in serum
fter 3 days p.i. further supports minimal replication of
ngineered derivatives following ip injection of adult
FIG. 7. Memory CD81 T-cell responses following SINp18 immuniza-
tion are protective. Female mice (n 5 8) immunized with 5 3 107 PFU
(open squares), 5 3 108 PFU (open diamonds), or nonimmunized
controls (open circles) were challenged by ip injection with 107 PFU
vp18. Ovaries were recovered at Day 6 after challenge and vp18 titers
determined by plaque assay on BHK cells.
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61T-CELL RESPONSES TO RECOMBINANT vp18 AND SINp18 VIRUSESmice. Despite the apparent lack of productive replication,
sufficient polypeptides are produced and processed in
vivo to activate class I-restricted responses specific for
p18. One mechanism may reside in the high levels of
gene expression achieved from subgenomic viral RNA
using rSIN vectors (Hahn et al., 1992; Xiong et al., 1989),
hus contributing to relatively effective class I presenta-
ion and CD81 T-cell priming.
The frequencies of p18-specific CD81 T cells elicited
y either vp18 or SINp18 were approximately four-
o fivefold higher by tetramer staining than by IFN-g
ELISPOT analysis, suggesting diversity in their activation
or differentiation state. This was supported by direct
intracellular IFN-g staining as described by Murali-
rishna et al. (1998) of splenocytes from vp18-infected
ice 7 days p.i. Following a 5-h peptide stimulation in the
bsence of exogenous IL-2, IFN-g production was de-
tectable in only 25 to 28% of tetramer1 CD81 T cells.
owever, boosting of SINp18-primed mice by vp18 re-
ulted in IFN-g production by 80% of tetramer1 CD81 T
ells (data not shown). These data confirm the presence
f functionally heterogeneous populations during the
cute primary response. By contrast, CD81 T cells
primed during many acute infections appear to be func-
tionally homogeneous (Busch et al., 1998; Flynn et al.,
998; Murali-Krishna et al., 1998). Although primed CD81
T cells without demonstrable function have been ob-
served in some antiviral and antitumor responses, such
functional diversity appears predominantly associated
with chronic activation during persistent infections (Berg-
mann et al., 1999; Callan et al., 1998; Romero et al., 1998;
ajac et al., 1998). However, despite the discrepancy
etween phenotypic and functional p18-specific CD81
populations, the relative differences between acute and
memory populations primed by one vector, or between
populations primed by either virus, remained similar,
independent of the method used for frequency assess-
ment. Attempts to detect either secreted or intracellular
cytokines other than IFN-g produced by p18-specific
CD81 T cells were unsuccessful. Potential downregula-
tion of CD81 effector function by a type 2 cytokine re-
ponse also did not appear to contribute to limited T-cell
ctivation, as type 2 cytokine secretion was overall low,
nd in fact higher in splenocytes from vp18- compared
ith SINp18-primed mice. Increased levels of IL-10 se-
retion by vp18-induced splenocytes during the acute
esponse, but not by memory cells, further suggested
V-activated macrophages rather than CD41 T cells as
he source of IL-10. Furthermore, similar to vp18, SINp18
licited substantial secretion of IFN-g by CD41 T cells,
s observed following other viral infections (Varga and
elsh, 1998). These data indicate priming of a type I
ytokine response to both viruses, which is effectively
ustained during memory.The development of attenuated viral vectors has be-
ome a major aim of vaccine research as a result of the
R
Cigh demands for safety standards. However, overat-
enuation can correlate with poor protective efficacy re-
ulting from inefficient cellular immune responses (John-
on et al., 1999). The present results demonstrate that
INp18 immunization is associated with effective main-
enance of memory CD81 T cells, with frequencies com-
rising up to 50% of the respective acute response,
imilar to vp18. Although SINp18 has a lower capacity to
nduce T-cell activation compared with vp18, the SIN
ector itself efficiently stimulates IL-2 and IFN-g produc-
ion, potentially contributing to effective maintenance of
emory. The protective capacity of rSIN-induced mem-
ry CD81 T cells was demonstrated by control of an
infectious vp18 challenge. These results thus establish
rSIN-based vectors as effective immunogens for gener-
ation of memory CD81 T cells, in the absence of exten-
ive replication and inflammatory components associ-
ted with rVV infection and confirm their efficiency as
rotective vaccines.
MATERIALS AND METHODS
ice and injections
Six-week-old BALB/c mice were purchased from Jack-
on Laboratories (Bar Harbor, ME) and housed in mi-
roisolator cages in an accredited animal facility at the
niversity of Southern California. For each experiment,
roups of mice were both sex- and age-matched. For all
mmunizations, groups of mice received 5 3107 PFU of
SINp18 or vp18 intraperitoneally (ip).
Viruses, virus titers, and cell lines
The derivation of vp18 encoding the 10-mer p18 pep-
tide from HIV-1IIIB gp160 has been described (Bergmann
et al., 1993, 1994). SINp18 expressing the identical
epitope was generated by inserting the NheI/SpeI mini-
gene encoding the peptide sequence from plasmid
pK18–10 (Bergmann et al., 1993) into the compatible XbaI
site of the parent SIN vector pTE392J (Hahn et al., 1992).
SINp18 stocks were generated following transfection of
BHK-21 cells with infectious in vitro transcribed mRNA
and titers determined using BHK cells (Hahn et al., 1992).
SIN titers in serum were determined by plaque assay on
BHK cells. Vaccinia virus titers in ovaries were deter-
mined by plaque assay on BSC-1 cells as described
(Binder and Ku¨ndig, 1991; Villacres and Bergmann, 1999).
The J774.1 (H-2d) macrophage cell line was propagated
as described (Bergmann et al., 1993).
Preparation of H-2Dd/p18 tetramers
The cDNA encoding Dd class I residues 1 to 274 of the
oluble heavy chain was amplified by PCR using plasmid
emplate pDdSEL.fix34 (generously provided by R.
ibaudo, NIH, MD). The 59 (59-TCT TCC ATG GGC TCA
AC TCG CTG AGG TAT) and 39 (59-AAG AGG ATC CTA
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62 VILLACRES, ZUO, AND BERGMANNATG CCA TTC GAT TTT CTG CGC TTC GAA GATATC GTT
CAG ACC GCC CC CCA TCT CAG GGT GAG GGG C)
primers were flanked by an NcoI restriction site incorpo-
rating the initiation codon and a BamHI restriction site
preceded by a stop codon, respectively. The sequence
encoding a substrate for the biotinylation enzyme BirA
(GGG LNDIFEAQKIEWH) was integrated into the 39 oligo-
nucleotide primer. The BirA sequence was thus geneti-
cally tagged to Dd residue Trp274. The PCR product was
digested with NcoI and BamHI and inserted into the
corresponding sites of plasmid pET-3d (Stratagene, La
Jolla, CA). The sequence was confirmed by dideoxy se-
quencing. Following induction with isopropyl-b-D-thioga-
lactopyranoside, the clone was transformed into the E.
coli strain BL21 (DE3). Human b2-microglobulin, ex-
pressed from the plasmid pHN1-b2m, was generously
rovided by J. Altman (Emory University, Atlanta, GA).
olding with the p18–10 peptide (RGPGRAFVTI), purifica-
ion, biotinylation, and generation of tetramers was per-
ormed as described (Altman et al., 1996; Murali-Krishna
et al., 1998).
Flow cytometry
Splenocytes from immunized or naive control mice
were incubated for 15 min at 4°C with 4% normal mouse
serum in PBS. Cells were stained with monoclonal anti-
body (mAb) to CD4 (RM4–5), CD8 (53–6.7), CD11a (M17/
4), CD44 (IM7), or CD62L (MEL-14) labeled with either
fluoroscein isothiocyanate (FITC) or phycoerytherin (PE).
All antibodies were used at 0.5 mg/106 cells and pur-
hased from PharMingen (San Diego, CA). For analysis
f p18-specific TCR expression, cells were stained with
oth FITC-labeled anti-CD8 and PE-labeled Dd/p18 tet-
amers (0.2 mg/106 cells). Ld tetramers prepared with the
pN peptide from mouse hepatitis virus (MHV) were used
as negative controls for specific staining (Bergmann et
al., 1999). Cells were analyzed in a FACScan flow cytom-
eter (Becton Dickinson, Mountain View, CA).
IFN-g-secreting cells, CTL assays, and synthetic
eptides
IFN-g-secreting cells were detected by peptide-spe-
ific ELISPOT assays as described (Miyahira et al., 1995).
Briefly, serial dilutions of splenocytes were added to
mAb-coated wells (R4–6A2 at 10 mg/ml concentration,
harMingen) and cultured with untreated or p18-peptide-
ulsed splenocytes from naive mice (2.5 3 105/well).
Recombinant human IL-2 was added to a final 50 U/ml
concentration and cultures were incubated for 18 h at
37°C. Bound IFN-g was detected by overnight incubation
at 4°C with a biotinylated anti-IFN-g mAb (XMG1.2,
harMingen), followed by incubation with streptavidin/
eroxidase and diamino benzidine/H2O2 as substrate(both from Sigma, St. Louis, MO). Dilutions were tested in
triplicate. Ex vivo cytolytic activity of splenocytes wasmeasured in a 4-h 51Cr-release assay using p18-peptide-
ensitized J774.1 cells as described previously (Berg-
ann et al., 1994). Peptide p18–10 (RGPGRAFVTI) was
ynthesized on an automated model 430A synthesizer
Applied Biosystems, Foster City, CA) by the USC Norris
ancer Center Microchemistry Core Laboratory and pu-
ified as described (Bergmann et al., 1994).
nrichment of CD41 or CD81 T cells
Splenocyte suspensions were depleted of CD41 or
D81 T cells by immunomagnetic separation. Briefly, cell
suspensions were incubated with rat anti-CD8 mAb (53–
6.7, PharMingen) at 4°C for 30 min, followed by binding
to anti-rat Ig-coated magnetic beads (Dynal, Lake Suc-
cess, NY). These preparations routinely contained 50–
55% CD41 T cells and ,1% CD81 T cells. Similarly, rat
anti-CD4 mAb (GK 1.5, PharMingen) was used to remove
CD41 T cells. These preparations contained 19–20%
D81 T cells and ,1.5% CD41 T cells.
Cytokine detection by ELISA
CD8-depleted splenocytes (1 3 106/ml) were stimu-
lated with UV-inactivated SINp18 or vp18. The inactivated
viruses were added at a concentration equivalent to a
multiplicity of infection of 20 before inactivation. Control
experiments demonstrated no infectious virus in UV-
inactivated preparations. Supernatants were harvested
at the indicated time points. Where indicated, a low
concentration of plate-bound anti-CD3e mAb (0.1 mg/ml,
clone 145-2C11, PharMingen) was used to stimulate cy-
tokine secretion by activated cells. For IFN-g secretion
y CD81 T cells, preparations depleted of CD41 T cells
ere stimulated with 1 mM p18 peptide and culture
upernatants tested for IFN-g. Culture medium was
Iscove’s modified Dulbecco’s medium supplemented
with 2 mM L-glutamine, 25 mg gentamicin, 1 mM sodium
pyruvate, 5 3 1025 M 2-mercaptoethanol and nonessen-
ial amino acids in the presence of 1.5% normal mouse
erum. Secreted IL-2, IL-4, IL-5, IL-10, and IFN-g were
measured in supernatants of CD8-depleted splenocytes
by ELISA. Paired capture and detecting mAb were JES6-
1A12 and JES6-5H4 for IL-2; 11B11 and BVD6-24G2 for
IL-4; TRFK5 and TRFK4 for IL-5; JES5-2A5 and SXC-1 for
IL-10; and R4-6A2 and XMG1.2 for IFN-g, respectively (all
from PharMingen). All detecting mAb were biotinylated.
Complexes were detected by incubation with streptavi-
din/peroxidase conjugate and reaction with o-phenyl-
enediamine dihydrochloride (both from Sigma). Recom-
binant cytokines (PharMingen) were used for the prepa-
ration of the respective standard curves. Each sample
was tested in duplicate. The detection limits were 30
pg/ml for IL-2, 5 pg/ml for IL-4, 50 pg/ml for IL-5 and IL-10,
and 200 pg/ml for IFN-g.
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Results were evaluated for statistical significance by
paired Student’s t test.
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